Biotech Updates

US Ambassador Visits Biotech Eggplant and Papaya Confined Trial Sites in the Philippines

March 14, 2008

United States Ambassador to the Philippines Kristie Kenney visited the confined trial site of the public-sector developed biotech eggplant and papaya in the campus of the University of the Philippines Los Banos (UPLB). The unveiling of a site marker on the confined trial facility highlighted the activity on March 10, 2008 to commemorate the progress achieved in US-Philippine partnership on biotech crop R&D. The confined trials are being conducted to obtain horticultural data and perform breeding and line selection activities on the fruit and shoot borer resistant (FSBR) eggplant and the papaya ringspot virus resistant (PRSV-R) papaya being developed by the UPLB-Institute of Plant Breeding before these crops are advanced to multi-location trials.

During the program, Ambassador Kenney said that she was very happy that the contributions from the American people went a long way and helped in the research and development of the two biotech crops and added that she believes that the crops would significantly impact small farmers in the Philippines.

The activity was also attended by USAID (Philippines) Deputy Director Elzadia Washington, USAID Chief of Energy and Environment Office Daniel Moore and by representatives from USDA-Foreign Agricultural Service (FAS) as well as UPLB's partner institutions including the International Service for the Acquisition of Agri-biotech Applications (ISAAA), Agricultural Biotechnology Support II Project (ABSPII), Philippine Council for Agriculture, Forestry and Natural Resources Research and Development (PCARRD), Southeast Asian Regional Center for Graduate Study and Research in Agriculture (SEARCA), and various government regulatory agencies.

(L-R) USAID’s Daniel Moore and Elzadia Washington, Ambassador Kristie Kenney, UPLB Chancellor Luis Rey Velasco, PCARRD Executive Director Patricio Faylon, ISAAA Global Coordinator Randy Hautea and IPB Director Jose Hernandez Jr.